当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 现金流量表

宏源药业

(301246)

  

流通市值:43.02亿  总市值:107.52亿
流通股本:1.60亿   总股本:4.00亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金798,157,077.42487,934,049.15200,764,860.341,121,247,787.84
  收到的税费返还24,837,813.6318,370,220.758,076,146.8439,963,876.3
  收到其他与经营活动有关的现金22,678,257.9118,249,538.4915,361,355.9225,857,835.09
  经营活动现金流入小计845,673,148.96524,553,808.39224,202,363.11,187,069,499.23
  购买商品、接受劳务支付的现金790,227,503.57517,968,616.37261,949,204.31924,940,600.79
  支付给职工以及为职工支付的现金163,503,294.83111,522,550.5463,238,102.75199,171,725.44
  支付的各项税费27,265,918.3222,688,800.188,088,610.0820,816,074.99
  支付其他与经营活动有关的现金50,066,353.3441,888,389.814,514,452.857,950,788.93
  经营活动现金流出小计1,031,063,070.06694,068,356.89347,790,369.941,202,879,190.15
  经营活动产生的现金流量净额-185,389,921.1-169,514,548.5-123,588,006.84-15,809,690.92
二、投资活动产生的现金流量:
  收回投资收到的现金4,184,646,241.392,621,620,299.07534,024,567.944,157,547,636.1
  取得投资收益收到的现金---61,500,000
  处置固定资产、无形资产和其他长期资产收回的现金净额1,834,205.94186,187.6258,294.691,363,421.08
  投资活动现金流入小计4,186,480,447.332,621,806,486.69534,082,862.634,220,411,057.18
  购建固定资产、无形资产和其他长期资产支付的现金131,292,020.4756,645,483.64,133,615.9160,196,638.68
  投资支付的现金4,697,000,0002,907,300,000811,500,0003,643,500,000
  取得子公司及其他营业单位支付的现金---3,203,429.6
  投资活动现金流出小计4,828,292,020.472,963,945,483.6815,633,615.93,806,900,068.28
  投资活动产生的现金流量净额-641,811,573.14-342,138,996.91-281,550,753.27413,510,988.9
三、筹资活动产生的现金流量:
  吸收投资收到的现金---470,000
  其中:子公司吸收少数股东投资收到的现金---470,000
  取得借款收到的现金448,000,000338,000,000118,374,779.1151,137,941.76
  收到其他与筹资活动有关的现金60,037,678.0143,042,716.3826,595,650.92-
  筹资活动现金流入小计508,037,678.01381,042,716.38144,970,430.0351,607,941.76
  偿还债务支付的现金133,054,00060,277,0007,777,00065,554,000
  分配股利、利润或偿付利息支付的现金23,532,444.1318,177,935.963,070,471.1230,864,761.22
  支付其他与筹资活动有关的现金15,346,726.3232,458,014.3914,354,018.93132,089,151.13
  筹资活动现金流出小计171,933,170.45110,912,950.3525,201,490.05228,507,912.35
  筹资活动产生的现金流量净额336,104,507.56270,129,766.03119,768,939.98-176,899,970.59
四、汇率变动对现金及现金等价物的影响581,007.55495,696.86657,329.264,980,565.43
五、现金及现金等价物净增加额-490,515,979.13-241,028,082.52-284,712,490.87225,781,892.82
  加:期初现金及现金等价物余额582,186,378.02582,186,378.02582,186,378.02356,404,485.2
  期末现金及现金等价物余额91,670,398.89341,158,295.5297,473,887.15582,186,378.02
补充资料:
  净利润--6,408,271.22-51,461,755.73
  资产减值准备-26,054,288.41-36,433,808.91
  固定资产和投资性房地产折旧-95,647,658.86-172,942,863.33
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-95,647,658.86-172,942,863.33
  无形资产摊销-2,385,489.47-4,797,304.09
  长期待摊费用摊销-1,427,568.19-3,358,861.92
  处置固定资产、无形资产和其他长期资产的损失--67,192.75--533,612.43
  固定资产报废损失-253,474.37-267,471.52
  公允价值变动损失--812,583.52--3,817,511.65
  财务费用-5,977,442.41-11,714,414.2
  投资损失--63,026.25--1,422,692.01
  递延所得税--1,495,838.04-385,396.73
  其中:递延所得税资产减少--1,598,485.01-301,125.09
    递延所得税负债增加-102,646.97-84,271.64
  存货的减少--49,839,346.94--74,749,149.76
  经营性应收项目的减少--218,683,753.19--168,428,628.62
  经营性应付项目的增加--24,376,011.08--57,731,251.63
  其他---8,618,011.28
  现金的期末余额-341,158,295.5-582,186,378.02
  减:现金的期初余额-582,186,378.02-356,404,485.2
  现金及现金等价物的净增加额--241,028,082.52-225,781,892.82
公告日期2025-10-232025-08-282025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑